{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:22:02Z","timestamp":1786119722023,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/iae.0b013e318205b228","type":"journal-article","created":{"date-parts":[[2011,3,10]],"date-time":"2011-03-10T03:15:42Z","timestamp":1299726942000},"page":"1279-1286","source":"Crossref","is-referenced-by-count":12,"title":["COMBINATION TREATMENT WITH INTRAVITREAL INJECTION OF RANIBIZUMAB AND REDUCED FLUENCE PHOTODYNAMIC THERAPY FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO ANGIOID STREAKS"],"prefix":"10.1097","volume":"31","author":[{"given":"Ozgur","family":"Artunay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdal","family":"Yuzbasioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifat","family":"Rasier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Sengul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Senel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"Bahcecioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210130","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0002-9343(61)90078-X","article-title":"Pseudoxanthoma elasticum and angioid streaks: a review of 106 cases.","volume":"30","author":"Connor","year":"1961","journal-title":"Am J Med"},{"key":"R2-7-20210130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/bjo.2007.129916","article-title":"Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum.","volume":"92","author":"Finger","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R3-7-20210130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9394(88)90014-1","article-title":"A long-term follow-up study of laser coagulation of neovascular membranes in angioid streaks.","volume":"105","author":"Gelisken","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"R5-7-20210130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0039-6257(82)90158-8","article-title":"Angioid streaks.","volume":"116","author":"Clarkson","year":"1982","journal-title":"Surv Ophthalmol"},{"key":"R6-7-20210130","first-page":"81","article-title":"Angioid streaks, clinical course, complications, and current therapeutic management.","volume":"5","author":"Georgalas","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"R7-7-20210130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0002-9394(02)01626-4","article-title":"Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks.","volume":"134","author":"Karacorlu","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R8-7-20210130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archopht.118.3.327","article-title":"A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.","volume":"118","author":"Sickenberg","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R9-7-20210130","first-page":"1","article-title":"Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks.","volume":"135","author":"Shaikh","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R10-7-20210130","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00006982-200410000-00013","article-title":"Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy.","volume":"24","author":"Menchini","year":"2004","journal-title":"Retina"},{"key":"R11-7-20210130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/112067210501500111","article-title":"Photodynamic therapy with verteporfin of choroidal neovascularization secondary to angioid streaks: conventional versus early retreatment.","volume":"15","author":"Ladas","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"R12-7-20210130","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ophtha.2005.02.011","article-title":"Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.","volume":"112","author":"Browning","year":"2005","journal-title":"Ophthalmology"},{"key":"R13-7-20210130","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.ophtha.2007.03.057","article-title":"Photodynamic therapy for angioid streaks.","volume":"114","author":"Browning","year":"2007","journal-title":"Ophthalmology"},{"key":"R14-7-20210130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00417-005-0131-3","article-title":"Long-term results of photodynamic therapy for the treatment of choroidal neovascularization secondary to angioid streaks.","volume":"244","author":"Arias","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R15-7-20210130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/bjo.2008.143461","article-title":"Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in patients with angioid streaks.","volume":"93","author":"Wiegand","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R16-7-20210130","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/IAE.0b013e31809ff5df","article-title":"Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum.","volume":"27","author":"Bhatnagar","year":"2007","journal-title":"Retina"},{"key":"R17-7-20210130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/bjo.2008.145896","article-title":"Long-term control of choroidal neovascularisation secondary to angioid streaks treated with intravitreal bevacizumab (Avastin).","volume":"93","author":"Neri","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R18-7-20210130","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ajo.2009.04.026","article-title":"Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.","volume":"148","author":"Sawa","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R19-7-20210130","first-page":"835","article-title":"Histopathological changes following photodynamic therapy in human eyes.","volume":"120","author":"Schmidt-Erfurth","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R20-7-20210130","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1167\/iovs.02-0604","article-title":"Sequence of early vascular events after photodynamic therapy.","volume":"44","author":"Michels","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-7-20210130","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1167\/iovs.02-1115","article-title":"Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelial-derived factor.","volume":"44","author":"Schmidt-Erfurth","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R22-7-20210130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1167\/iovs.05-0354","article-title":"Influence of treatment parameters on selectivity of verteporfin therapy.","volume":"47","author":"Michels","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-7-20210130","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/IAE.0b013e31817082d7","article-title":"Combination treatment with reduced-fluence photodynamic therapy and intravitreal injection of triamcinolone for subfoveal choroidal neovascularization in macular degeneration.","volume":"28","author":"Singh","year":"2008","journal-title":"Retina"},{"key":"R24-7-20210130","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archopht.123.4.448","article-title":"Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.","volume":"123","author":"Azab","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R25-7-20210130","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration.","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"R26-7-20210130","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ophtha.2005.10.052","article-title":"Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I\/II multicenter, controlled, multidose study.","volume":"113","author":"Heier","year":"2006","journal-title":"Ophthalmology"},{"key":"R27-7-20210130","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2165\/00002512-200724120-00002","article-title":"Combination therapy for choroidal neovascularisation.","volume":"24","author":"Augustin","year":"2007","journal-title":"Drugs Aging"},{"key":"R28-7-20210130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/archopht.123.4.509","article-title":"Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.","volume":"123","author":"Husain","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R29-7-20210130","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1136\/bjo.2007.135335","article-title":"Combination of verteporfin photodynamic therapy and ranibizumab: effects on retinal anatomy, choroidal perfusion and visual function in the PROTECT study.","volume":"92","author":"Kiss","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R30-7-20210130","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/IAE.0b013e3181c596b1","article-title":"Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum.","volume":"30","author":"Myung","year":"2010","journal-title":"Retina"},{"key":"R31-7-20210130","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/archopht.124.11.1532","article-title":"Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.","volume":"124","author":"Heier","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"R32-7-20210130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1755-3768.2009.01754.x","article-title":"Intravitreal ranibizumab as primary treatment for neovascular membrane associated with angioid streaks.","volume":"88","author":"Lazaros","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R33-7-20210130","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1038\/eye.2009.158","article-title":"Intravitreal ranibizumab for choroidal neovascularisation secondary to angioid streaks.","volume":"23","author":"Kang","year":"2009","journal-title":"Eye"},{"key":"R34-7-20210130","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/IAE.0b013e3181d2f11d","article-title":"Intravitreal ranibizumab treatment of macular choroidal neovascularization secondary to angioid streaks: one-year results of a prospective study.","volume":"30","author":"Ladas","year":"2010","journal-title":"Retina"},{"key":"R35-7-20210130","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/IAE.0b013e3181cafc75","article-title":"Angioid streak-related choroidal neovascularization treated by intravitreal ranibizumab.","volume":"30","author":"Vadala","year":"2010","journal-title":"Retina"},{"key":"R36-7-20210130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/bjo.2009.159160","article-title":"Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials.","volume":"94","author":"Mitchell","year":"2010","journal-title":"Br J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0b013e318205b228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:55:46Z","timestamp":1786042546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-201107000-00007"}},"subtitle":["Preliminary Clinical Results of 12-Month Follow-Up"],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e318205b228","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}